Evidence map›Paper›PMID 24311866›Full record

ArticleAfrican journal of traditional, complementary, and alternative medicines : AJTCAM2013

Treating cardiovascular atherosclerotic plaques with Tongmaijiangzhi (TMJZ) capsule.

Hong-Qiang Ren, Li Zhao, Zhong Shuang Zhang, Zhong Wang, Li Wang, Jun Cang Duan, Li Li, Zhi Hong Zhai, De Tao Qu, Hui Huang

Open access · diamondAbstract read
PubMed Full text at PMC
In one paragraph

Article in African journal of traditional, complementary, and alternative medicines : AJTCAM, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Hong-Qiang Ren *Department of Cardiology, the First Affiliated Hospital, Medical College of Shihezi University, 832008.
Li Zhao *Medical College of Shihezi University, 832000.
Zhong Shuang ZhangMedical College of Shihezi University, 832000.
Zhong WangDepartment of Cardiology, the First Affiliated Hospital, Medical College of Shihezi University, 832008.
Li WangDepartment of Cardiology, the First Affiliated Hospital, Medical College of Shihezi University, 832008.
Jun Cang DuanDepartment of Cardiology, the First Affiliated Hospital, Medical College of Shihezi University, 832008.
Li LiDepartment of Cardiology, the First Affiliated Hospital, Medical College of Shihezi University, 832008.
Zhi Hong ZhaiDepartment of Cardiology, the First Affiliated Hospital, Medical College of Shihezi University, 832008.
De Tao QuDepartment of Cardiology, the First Affiliated Hospital, Medical College of Shihezi University, 832008.
Hui HuangDepartment of Cardiology, the First Affiliated Hospital, Medical College of Shihezi University, 832008.
First Affiliated Hospital of Shihezi University Medical College · CNShihezi University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atherosclerotic plaques can cause serious syndromes and mortality. Cholesterol accumulation in the plaques can disrupt the arterial flow, with lumen narrowing and stenosis, which contributes to heart attack and sudden cardiac death. The pharmacological treatment to atherosclerotic plaques can be anti-hypertensives, anti-cholesterol, and cleaning of the existed plaques. This work examined the effects of pharmacological Tongmaijiangzhi (TMJZ) capsule on atherosclerotic plaques. The radiological findings of the atherosclerotic plaques of 107 patients receiving TMJZ treatment were analyzed. We found that the TMJZ administration decreases plaque volume and alters the composition in a relatively short period, showing highly promising effects. TMJZ treatment is able to remove the existed atherosclerotic plaques with no side effects observed.

Indexed as

PhytotherapyAgedAged, 80 and overCarotid StenosisDrugs, Chinese HerbalEquisetumFemaleHumansLigusticumMaleMiddle AgedMultidetector Computed TomographyNelumboPanax notoginsengPlaque, AtheroscleroticTreatment Outcomechuangxiong extractDrugs, Chinese HerbalAtherosclerotic plaqueshypertensionstenosisTongmaijiangzhi

Identifiers

PMID24311866
PMCPMC3847381
OpenAlexW2071654840

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.